Global coronary stent market was valued at $10.9 billion in 2025 and is growing at a CAGR of 5.1% during the forecast period (2026-2035). Balloon-expandable stents play a central role in coronary stent interventions due to their controlled deployment, precise positioning, and strong radial support, which are critical in treating coronary artery disease. These stents are expanded using an inflatable balloon, allowing clinicians to achieve accurate placement within narrowed coronary arteries. The predictable expansion behavior supports optimal vessel scaffolding and uniform lesion coverage during percutaneous coronary interventions. Balloon-expandable stents are widely compatible with advanced drug-eluting technologies, contributing to reduced restenosis rates and improved long-term outcomes. The extensive clinical use, established procedural familiarity, and consistent performance across a wide range of coronary lesions reinforce their continued importance in coronary revascularization practices globally.
Browse the full report description of “Coronary Stent Market Size, Share & Trends Analysis by Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bioabsorbable Stents), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/coronary-stent-market
Moreover, clinical evidence highlights the safety and effectiveness of drug-coated balloon therapies, increasing interest in implant-free or reduced-implant treatments and contributing to market growth in coronary interventions.For instance, in October 2025, new research from a Mount Sinai-led trial indicates that a new drug-eluting balloon, coated with sirolimus, demonstrates comparable safety and effectiveness to conventional metal stents for patients experiencing coronary in-stent restenosis during repeat percutaneous coronary interventions. This landmark US-regulated study is the largest randomized trial of its kind, potentially paving the way for a safer and more straightforward treatment option for these patients.
Key Innovators Driving Coronary Stent Transformation
The key players in the coronary stent market include Abbott Laboratories, Braun Melsungen AG, Boston Scientific Corp., Medtronic Plc, Terumo Corp., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.
Market Coverage
Key questions addressed by the report.
Global Coronary Stent Market Report Segment
By Mode of Delivery
By Type
Global Coronary Stent Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/construction-chemicals-market-size